John E Jett

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

David P. Walling, Stephen R. Marder, John M. Kane et al. · Schizophrenia Bulletin · 2015 · 96 citations · Full text

Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics

John E Jett, Michael McLaughlin, Mark S. Lee et al. · American Journal of Clinical Dermatology · 2021 · 38 citations · Full text

A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis

Stephen C. Piscitelli, Ana B. Pavel, Kimberly McHale et al. · Journal of Investigative Dermatology · 2021 · 27 citations

Phase 1B, Topical Cerdulatinib, Single-center Trial +5

Dermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials

John E Jett, Timothy R. Wilson, Matthew C. Somerville et al. · Journal of Drugs in Dermatology · 2022 · 14 citations · Full text

Identification and pharmacological characterization of 3,6-diazabicyclo[3.1.1]heptane-3-carboxamides as novel ligands for the α4β2 and α6/α3β2β3 nicotinic acetylcholine receptors (nAChRs)

Jon‐Paul Strachan, David C. Kombo, Anatoly Mazurov et al. · European Journal of Medicinal Chemistry · 2014 · 10 citations · Full text